ViiV healthcare development program on cabotegravir and rilivirine has no pandemic interruptions

▴ ViiV healthcare development program on cabotegravir and rilivirine has no pandemic interruptions
ViiV Healthcare, today announced the positive findings of a pooled analysis of COVID-19-related impacts across the investigational long-acting cabotegravir and rilpivirine clinical development programme.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced the positive findings of a pooled analysis of COVID-19-related impacts across the investigational long-acting cabotegravir and rilpivirine clinical development programme. In the midst of the global pandemic, the analysis found no antiretroviral therapy interruptions across the entirety of the ongoing clinical development programme for long-acting cabotegravir and rilpivirine.

When missed visits occurred due to the pandemic, the analysis showed they were manageable and successfully mitigated primarily by switching patients onto short periods of daily oral therapy of cabotegravir and rilpivirine, with good tolerability and no virologic failure or emerging resistance. 

Tags : #LatestPharmaNewsOct21 #LatestGskNewsOct21 #TreatmentofHIV1infection #Antiretroviraltherapy

About the Author


Sana Farid Khan

“The best way to become acquainted with a subject is to write about it."
A confident counselor, a speaker, and an educator, ready to utilize my communication skills effectively in the world of healthcare by putting pen to paper to reach new heights of success.
You can write to me at [email protected]

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

Discussing Sexual Health is a Taboo! Expert Urologist, Dr.Anil Elhence sheds light upon some vital issues of sexual health concerning society as a wholeFebruary 27, 2021
27th February – Anosmia Awareness DayFebruary 27, 2021
To use my learnings to impact the lives of those who did not have the privilege to learn is most satisfying, says Saji Mathew, Chief Operating Officer, Baby Memorial HospitalFebruary 27, 2021
“I can & I will !!” - The Thought Behind Spreading Awareness of Cancer by Dr.Sachin Marda, Eminent Oncologist February 26, 2021
Get into “zen”mode for your mental health with these tips February 26, 2021
Sex Education Should be Normalized, says Dr. Shivadev M, Psychiatrist, and Sexual Wellness ExpertFebruary 26, 2021
Learn Everything about Broken Heart Syndrome. February 25, 2021
Why Should A Woman give Importance to Mental Health?February 25, 2021
Healthy Living for an Improved Cancer Scenario in India, explained by Dr. Amol Akhade, Senior Consultant Medical Oncologist, Hemato-Oncologist and Bone Marrow Transplant PhysicianFebruary 25, 2021
Dr. Latika Chawla, Obstetrician and Gynaecological Endoscopic Surgeon advises women to take care of their sexual and reproductive health and be open to discuss it with specialists without inhibitionFebruary 25, 2021
COVID-19: Maharashtra’s Latur district administration to implement 'Janata curfew' on February 27 and 28February 25, 2021
Covid-19 antibodies offers protection against reinfection later, study suggests February 25, 2021
People traveling to Delhi from states with spike in COVID-19 cases to show negative RT-PCR test from 26th FebFebruary 25, 2021
An Overview of Leprosy by Dr. Nitin Sampat, Senior NeurologistFebruary 25, 2021
India starts shipping COVID-19 vaccines to Africa under COVAX facilityFebruary 25, 2021
Govt to commence administering COVID-19 vaccine to people above 60 yrs of age from 1st MarchFebruary 24, 2021
Cabinet approves production linked incentive scheme for pharmaceuticalsFebruary 24, 2021
‘Night owls’ may be twice as likely as morning ‘larks’ to underperform at workFebruary 24, 2021
Soleno Therapeutics announces collaboration with Vanderbilt University February 24, 2021
Exercise, Yoga, and Meditation are ways to deal with RA, suggests Dr. S. Sham, Consultant Rheumatologist February 24, 2021